Old Republic International Corp Astrazeneca PLC Transaction History

Old Republic International Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$36.86 - $41.49 $26.6 Million - $30 Million	-722,000 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$34.55 - $37.05 $18.3 Million - $19.7 Million	-531,000 Reduced 42.38%	722,000 $25.3 Million
Q4 2017 Feb 20, 2018	BUY	$32.09 - $34.78 $9.69 Million - $10.5 Million	302,000 Added 31.76%	1,253,000 $43.5 Million
Q3 2017 Nov 01, 2017	BUY	$28.96 - $34.0 $27.5 Million - $32.3 Million	951,000	951,000 $32.2 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Old Republic International Corp, based on Form 13F filings with the SEC.

Stay updated on Old Republic International Corp with notifications on news.